Cargando…

High prevalence of low bone mineral density in patients within 10 years of onset of ankylosing spondylitis: a systematic review

Ankylosing spondylitis (AS) is a chronic inflammatory rheumatic disease. Decreased bone mineral density (BMD) is a common complication of AS, with a prevalence range of 19 to 62 %. Many studies have shown decreased BMD in AS with long disease duration, but only a few studies investigated BMD in earl...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Weijden, M. A. C., Claushuis, T. A. M., Nazari, T., Lems, W. F., Dijkmans, B. A. C., van der Horst-Bruinsma, I. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483100/ https://www.ncbi.nlm.nih.gov/pubmed/22706444 http://dx.doi.org/10.1007/s10067-012-2018-0

Ejemplares similares

Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies
por: van der Weijden, M. A. C., et al.
Publicado: (2010)

Bone formation rather than inflammation reflects Ankylosing Spondylitis activity on PET-CT: a pilot study
por: Bruijnen, Stefan TG, et al.
Publicado: (2012)

Moving instead of asking? Performance-based tests and BASFI-questionnaire measure different aspects of physical function in ankylosing spondylitis
por: van Weely, Salima FE, et al.
Publicado: (2012)

Discovertebral (Andersson) lesions of the spine in ankylosing spondylitis revisited
por: Bron, Johannes L., et al.
Publicado: (2009)

Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
por: Visvanathan, S, et al.
Publicado: (2008)

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis
por: Arends, Suzanne, et al.
Publicado: (2020)

Cardiovascular risk management in patients with active Ankylosing Spondylitis: a detailed evaluation
por: Heslinga, Sjoerd C, et al.
Publicado: (2015)

The effect of anti-TNF on renal function in patients with ankylosing spondylitis: a prospective cohort study
por: Swart, I. A. P., et al.
Publicado: (2022)

Predicting the outcome of ankylosing spondylitis therapy
por: Vastesaeger, Nathan, et al.
Publicado: (2011)

The effects of golimumab treatment on systolic and diastolic left ventricular function in ankylosing spondylitis
por: Heslinga, SC, et al.
Publicado: (2018)

Discovertebral (Andersson) lesions in severe ankylosing spondylitis: a study using MRI and conventional radiography
por: de Vries, Mirjam K., et al.
Publicado: (2010)

[(18)F]Fluoride PET provides distinct information on disease activity in ankylosing spondylitis as compared to MRI and conventional radiography
por: de Jongh, Jerney, et al.
Publicado: (2022)

Bone microarchitecture in ankylosing spondylitis and the association with bone mineral density, fractures, and syndesmophytes
por: Klingberg, Eva, et al.
Publicado: (2013)

The bone mineral density of hip joint was reduced in the initial stage of ankylosing spondylitis?
por: Cai, Peng Li, et al.
Publicado: (2020)

Aortic root diameter is associated with HLA-B27: identifying the patient with ankylosing spondylitis at risk for aortic valve regurgitation
por: Baniaamam, M., et al.
Publicado: (2021)

The Prevalence of Cardiac Diseases in a Contemporary Large Cohort of Dutch Elderly Ankylosing Spondylitis Patients—The CARDAS Study
por: Baniaamam, Milad, et al.
Publicado: (2021)

Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice
por: Rusman, Tamara, et al.
Publicado: (2018)

Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
por: Ramiro, Sofia, et al.
Publicado: (2013)

Factors relating to bone mineral density in young and middle-aged patients with ankylosing spondylitis
por: Wu, Xin, et al.
Publicado: (2021)

Interaction effects of significant risk factors on low bone mineral density in ankylosing spondylitis
por: Sun, Wenting, et al.
Publicado: (2023)

A Pooled Analysis Reporting the Efficacy and Safety of Secukinumab in Male and Female Patients with Ankylosing Spondylitis
por: van der Horst-Bruinsma, Irene, et al.
Publicado: (2021)

The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis
por: Arends, S., et al.
Publicado: (2010)

Adalimumab effectiveness for the treatment of ankylosing spondylitis is maintained for up to 2 years: long-term results from the ATLAS trial
por: van der Heijde, D, et al.
Publicado: (2008)

Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)

Peripheral quantitative computed tomography in the assessment of bone mineral density in anti-TNF-treated rheumatoid arthritis and ankylosing spondylitis patients
por: Juhász, Balázs, et al.
Publicado: (2021)

Long-term efficiency of infliximab in patients with ankylosing spondylitis: real life data confirm the potential for dose reduction
por: Baraliakos, X, et al.
Publicado: (2016)

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study
por: Webers, Casper, et al.
Publicado: (2018)

Bone and Cartilage Turnover Markers, Bone Mineral Density, and Radiographic Damage in Men with Ankylosing Spondylitis
por: Park, Min-Chan, et al.
Publicado: (2008)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
por: Braun, J, et al.
Publicado: (2011)

Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis
por: van der Heijde, Désirée, et al.
Publicado: (2019)

Changes in bone mineral density and bone metabolic indexes in ankylosing spondylitis mouse model complicated with osteoporosis
por: Hu, Zi-Bing, et al.
Publicado: (2018)

Immune mechanism of low bone mineral density caused by ankylosing spondylitis based on bioinformatics and machine learning
por: Zhang, Ding, et al.
Publicado: (2022)

Ankylosing spondylitis
Publicado: (1980)

Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010)

Ankylosing Spondylitis
por: Ebrahimiadib, Nazanin, et al.
Publicado: (2021)

Accelerated hand bone mineral density loss is associated with progressive joint damage in hands and feet in recent-onset rheumatoid arthritis
por: Güler-Yüksel, Melek, et al.
Publicado: (2010)

Higher Bone Turnover Is Related to Spinal Radiographic Damage and Low Bone Mineral Density in Ankylosing Spondylitis Patients with Active Disease: A Cross-Sectional Analysis
por: Arends, Suzanne, et al.
Publicado: (2014)

Bone edema on magnetic resonance imaging is highly associated with low bone mineral density in patients with ankylosing spondylitis
por: Wang, Danmin, et al.
Publicado: (2017)

The bone bridge significantly affects the decrease in bone mineral density measured with quantitative computed tomography in ankylosing spondylitis
por: Lee, So Yun, et al.
Publicado: (2021)

Infliximab in the treatment of ankylosing spondylitis
por: Grainger, Rebecca, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_i145nv17he2jupvtjdcro5eeu1